JP2023522725A5 - - Google Patents
Info
- Publication number
- JP2023522725A5 JP2023522725A5 JP2022564050A JP2022564050A JP2023522725A5 JP 2023522725 A5 JP2023522725 A5 JP 2023522725A5 JP 2022564050 A JP2022564050 A JP 2022564050A JP 2022564050 A JP2022564050 A JP 2022564050A JP 2023522725 A5 JP2023522725 A5 JP 2023522725A5
- Authority
- JP
- Japan
- Prior art keywords
- isomer
- pharmaceutically acceptable
- methylazetidine
- heptan
- azabicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20200047190 | 2020-04-20 | ||
| KR10-2020-0047190 | 2020-04-20 | ||
| PCT/KR2021/004887 WO2021215765A1 (ko) | 2020-04-20 | 2021-04-19 | 3-아자바이사이클로알킬 유도체 및 이를 포함하는 약제학적 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522725A JP2023522725A (ja) | 2023-05-31 |
| JP2023522725A5 true JP2023522725A5 (cg-RX-API-DMAC7.html) | 2024-04-26 |
| JP7618338B2 JP7618338B2 (ja) | 2025-01-21 |
Family
ID=78232792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022564050A Active JP7618338B2 (ja) | 2020-04-20 | 2021-04-19 | 3-アザビシクロアルキル誘導体およびこれを含む薬剤学的組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230203008A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4134366A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7618338B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102614659B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115667244B (cg-RX-API-DMAC7.html) |
| TW (1) | TWI810550B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021215765A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021129737A1 (zh) | 2019-12-24 | 2021-07-01 | 南京明德新药研发有限公司 | 具有khk抑制作用的化合物 |
| WO2022022476A1 (zh) * | 2020-07-28 | 2022-02-03 | 山东轩竹医药科技有限公司 | 己酮糖激酶抑制剂的盐、晶型及其用途 |
| EP4269404A4 (en) * | 2020-12-25 | 2024-12-04 | Xizang Haisco Pharmaceutical Co., Ltd. | KETOHEXOKINASE INHIBITORS AND USE THEREOF |
| JP2024544794A (ja) * | 2021-12-24 | 2024-12-04 | エルジー・ケム・リミテッド | (s)-2-(2-メチルアゼチジン-1-イル)ピリミジン誘導体およびそれを含む医薬組成物 |
| US20250145619A1 (en) * | 2022-02-09 | 2025-05-08 | Youngene Therapeutics Co., Ltd | Khk inhibitor, preparation method therefor and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015359624B2 (en) * | 2014-12-08 | 2020-01-02 | Janssen Sciences Ireland Uc | Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV) |
| TN2018000198A1 (en) * | 2015-12-29 | 2019-10-04 | Pfizer | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors |
| KR102558308B1 (ko) * | 2018-09-27 | 2023-07-24 | 주식회사 엘지화학 | 3-아자바이사이클로[3,1,1]헵탄 유도체 및 이를 포함하는 약제학적 조성물 |
| WO2020156445A1 (zh) * | 2019-01-29 | 2020-08-06 | 山东轩竹医药科技有限公司 | 己酮糖激酶抑制剂及其用途 |
| EP4269404A4 (en) * | 2020-12-25 | 2024-12-04 | Xizang Haisco Pharmaceutical Co., Ltd. | KETOHEXOKINASE INHIBITORS AND USE THEREOF |
-
2021
- 2021-04-19 EP EP21793225.0A patent/EP4134366A4/en not_active Withdrawn
- 2021-04-19 JP JP2022564050A patent/JP7618338B2/ja active Active
- 2021-04-19 KR KR1020210050451A patent/KR102614659B1/ko active Active
- 2021-04-19 TW TW110113936A patent/TWI810550B/zh active
- 2021-04-19 CN CN202180036112.0A patent/CN115667244B/zh active Active
- 2021-04-19 WO PCT/KR2021/004887 patent/WO2021215765A1/ko not_active Ceased
- 2021-04-19 US US17/996,634 patent/US20230203008A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI670270B (zh) | 包含jak抑制劑之醫藥組合物 | |
| TWI526425B (zh) | 二環性γ-胺基酸衍生物之製造中間體 | |
| TWI734134B (zh) | 作為trk激酶抑制劑的大環化合物 | |
| JP6537527B2 (ja) | Jak及びpi3k阻害剤併用によるb細胞悪性腫瘍の処置 | |
| EP2729448B1 (en) | Compounds for the treatment of hiv | |
| JP7222590B2 (ja) | 3-アザビシクロ[3,1,1]ヘプタン誘導体及びこれを含む薬学的組成物 | |
| JP2025114615A (ja) | 治療薬としての細胞毒素のペプチドコンジュゲート | |
| CN113993590A (zh) | 新型egfr抑制剂 | |
| JP4881725B2 (ja) | Tie−2モジュレータと使用方法 | |
| CN105473573B (zh) | 用作激酶抑制剂的咔唑甲酰胺化合物 | |
| EP2152712A1 (en) | Amino-heterocyclic compounds | |
| RU2010150799A (ru) | НОВАЯ КРИСТАЛЛИЧЕСКАЯ И АМОРФНАЯ ФОРМА ТРИАЗОЛО(4,5-d)ПИРИМИДИНА | |
| CN103214484A (zh) | 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶 | |
| CN101863886A (zh) | 用作生长激素促分泌素的杂环芳香化合物 | |
| CN102076650A (zh) | 羧酸化合物 | |
| TW201249836A (en) | 4-phenylamino-6-butenamide-7-alkyloxy quinazoline derivatives, preparative method and use thereof | |
| JP7618338B2 (ja) | 3-アザビシクロアルキル誘導体およびこれを含む薬剤学的組成物 | |
| TW200538112A (en) | Novel compounds | |
| WO2020007322A1 (zh) | 一种靶向降解bet蛋白的化合物及其应用 | |
| CN105612162A (zh) | 作为nmda受体活性的调节剂的噻唑并嘧啶酮类 | |
| JP6929857B2 (ja) | 6,7,8,9−テトラヒドロ−5H−ピリド[2,3−d]アゼピンドーパミンD3リガンド | |
| TW201827406A (zh) | Nrf2活化劑 | |
| JP2023521237A (ja) | 抗ウイルス1,3-ジ-オキソ-インデン化合物 | |
| JP2025527291A5 (cg-RX-API-DMAC7.html) | ||
| MX2010012540A (es) | Derivados de imidazo[2,1-b]quinazolin-2-ona y su uso como agentes para inhibir la agregación plaquetaria. |